1. Home
  2. NBTX vs CMPR Comparison

NBTX vs CMPR Comparison

Compare NBTX & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

N/A

Current Price

$39.35

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Logo Cimpress plc (Ireland)

CMPR

Cimpress plc (Ireland)

N/A

Current Price

$87.58

Market Cap

2.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
NBTX
CMPR
Founded
2003
1994
Country
France
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
2018
2005

Fundamental Metrics

Financial Performance
Metric
NBTX
CMPR
Price
$39.35
$87.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$36.00
$86.50
AVG Volume (30 Days)
153.6K
168.3K
Earning Date
03-31-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
553.45
EPS
N/A
3.79
Revenue
N/A
$3,736,643,000.00
Revenue This Year
$58.17
$10.43
Revenue Next Year
N/A
$5.46
P/E Ratio
N/A
$23.06
Revenue Growth
N/A
9.80
52 Week Low
$8.41
$56.34
52 Week High
$57.14
$106.58

Technical Indicators

Market Signals
Indicator
NBTX
CMPR
Relative Strength Index (RSI) 48.30 39.51
Support Level $36.98 $86.93
Resistance Level $41.06 $105.61
Average True Range (ATR) 2.95 2.93
MACD -0.29 -0.00
Stochastic Oscillator 15.87 25.75

Price Performance

Historical Comparison
NBTX
CMPR

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

About CMPR Cimpress plc (Ireland)

Cimpress PLC helps millions of businesses build brands, stand out, and grow via customized physical marketing products and branded merchandise. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. It has five segments VistaPrint, PrintBrothers, The Print Group, National Pen, and All Other Businesses. Majority of revenue comes from VistaPrint segment which provides graphic design services, VistaCreate for do-it-yourself (DIY) design, etc. It has presence in North America, Europe, and Other. The company generates majority of revenue is from Europe.

Share on Social Networks: